Genetic and epigenetic biomarkers of colorectal cancer

Miew Keen Choong*, Guy Tsafnat

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

39 Citations (Scopus)


Cancer is a heterogeneous disease caused, in part, by genetic and epigenetic alterations. These changes have been explored in studies of the pathogenesis of colorectal cancer (CRC) and have led to the identification of many biomarkers of disease progression. However, the number of biomarkers that have been incorporated into clinical practice is surprisingly small. We review the genetic and epigenetic mechanisms of colorectal cancer and discuss molecular markers recommended for use in early detection, screening, diagnosis, determination of prognosis, and prediction of treatment outcomes. We also review important areas for future research.

Original languageEnglish
Pages (from-to)9-15
Number of pages7
JournalClinical Gastroenterology and Hepatology
Issue number1
Publication statusPublished - Jan 2012
Externally publishedYes


Dive into the research topics of 'Genetic and epigenetic biomarkers of colorectal cancer'. Together they form a unique fingerprint.

Cite this